A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials (Q5057002): Difference between revisions

From MaRDI portal
RedirectionBot (talk | contribs)
Removed claim: author (P16): Item:Q2306250
ReferenceBot (talk | contribs)
Changed an Item
 
(4 intermediate revisions by 4 users not shown)
Property / author
 
Property / author: James M. S. Wason / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W3137447442 / rank
 
Normal rank
Property / Wikidata QID
 
Property / Wikidata QID: Q111149820 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4264744 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sampling / rank
 
Normal rank
Property / cites work
 
Property / cites work: Group Sequential and Confirmatory Adaptive Designs in Clinical Trials / rank
 
Normal rank

Latest revision as of 02:44, 31 July 2024

scientific article; zbMATH DE number 7632881
Language Label Description Also known as
English
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials
scientific article; zbMATH DE number 7632881

    Statements

    A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    14 December 2022
    0 references
    assurance
    0 references
    expected power
    0 references
    probability of success
    0 references
    power
    0 references
    sample size derivation
    0 references

    Identifiers